Rapamycin: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
==Structure== | ==Structure== | ||
<StructureSection load=' | <StructureSection load='' size='340' side='right' caption='' scene='82/821566/Rapamycin/1'> | ||
[[Image:Rapamycin.png]] | [[Image:Rapamycin.png]] | ||
Revision as of 14:26, 17 July 2019
Rapamycin, isolated from the bacterium Streptomyces hygroscopicus, is an immuno-suppressant and anticancer drug[1]. It acts by binding the the mTORC1 protein complex, a kinase that regulates cell growth and metabolism. In the future, it might also be used in treatment of type 2 diabetes[2].
Structure
| |||||||||||
